SCHEMBL492737

SCHEMBL492737

O=C(O)c1nsc2nc(Cl)ccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.34
ALDH1A1 P00352 4/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 4/20 0.33
MEN1 O00255 3/20 0.33
CYP2C9 P11712 2/20 0.33
HSD17B10 Q99714 2/20 0.33
CYP1A2 P05177 1/20 0.33
DAO P14920 1/20 0.32
ATM Q13315 1/20 0.31
MCL1 Q07820 1/20 0.31
KMO O15229 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
CYP2C19 P33261 1/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
PPARG P37231 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL492627 0.71 IDO1 (0.32)
SCHEMBL492121 0.70 KDM4E (0.32) ALDH1A1KDM4E
SCHEMBL492026 0.70 KDM4E (0.47) NAPRTALDH1A1SMN1; SMN2MAPTKMT2A
SCHEMBL357264 0.69 DHODH (0.39) NAPRTALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL492471 0.69 MCL1 (0.50) ALDH1A1SMN1; SMN2MAPTKMT2AMEN1
Clopyralid SCHEMBL8535196 0.69 KMT2A (0.50) NAPRTALDH1A1SMN1; SMN2MAPTKMT2A
Clopyralid SCHEMBL54779 0.69 KMT2A (0.50) NAPRTALDH1A1SMN1; SMN2MAPTKMT2A
Clopyralid SCHEMBL29371357 0.69 KMT2A (0.50) NAPRTALDH1A1SMN1; SMN2MAPTKMT2A
Clopyralid SCHEMBL2403527 0.67 KMT2A (0.49) NAPRTALDH1A1SMN1; SMN2MAPTKMT2A
Clopyralid SCHEMBL726319 0.67 KMT2A (0.49) NAPRTALDH1A1SMN1; SMN2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273891-B2 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION (US) 2012-09-25 US disclosed
US-8106066-B2 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION (US) 2012-01-31 US disclosed
US-20100137288-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF SCHUMACHER RICHARD 2010-06-03 US disclosed
US-20070078147-A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION 2007-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137288-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, AND PREPARATION AND USES THEREOF CHRNA7, CHRNA5, CHRNA2 NAPRT 65/4885ALDH1A1 1707/4885SMN1; SMN2 1646/4885
US-20070078147-A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof CHRNA7, CHRNA5, CHRNA2 NAPRT 65/4885ALDH1A1 1707/4885SMN1; SMN2 1646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.